N-(2-chlorophenyl)-2-methyl-6-phenylimidazo[1,2-a]pyridine-3-carboxamide

ID: ALA1077738

PubChem CID: 46882743

Max Phase: Preclinical

Molecular Formula: C21H16ClN3O

Molecular Weight: 361.83

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1nc2ccc(-c3ccccc3)cn2c1C(=O)Nc1ccccc1Cl

Standard InChI:  InChI=1S/C21H16ClN3O/c1-14-20(21(26)24-18-10-6-5-9-17(18)22)25-13-16(11-12-19(25)23-14)15-7-3-2-4-8-15/h2-13H,1H3,(H,24,26)

Standard InChI Key:  WHMNCKBUNQISMC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   -3.5556  -26.6166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5568  -27.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8419  -27.8569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8437  -26.2039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1284  -26.6130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1235  -27.4394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3360  -27.6903    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8541  -27.0188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3439  -26.3531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3268  -25.5300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6050  -25.1306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0337  -25.1046    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0187  -24.2797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2922  -23.8837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2769  -23.0596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9820  -22.6405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7085  -23.0371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7203  -23.8599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4409  -24.2617    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.2681  -26.2045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2669  -25.3784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9807  -24.9661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6960  -25.3788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6932  -26.2081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9788  -26.6166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0291  -27.0139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
 12 13  1  0
  3  6  1  0
 13 14  2  0
  1  2  1  0
 14 15  1  0
  5  4  1  0
 15 16  2  0
  6  7  2  0
 16 17  1  0
  7  8  1  0
 17 18  2  0
 18 13  1  0
  8  9  2  0
 18 19  1  0
  9  5  1  0
  4  1  2  0
 20 21  2  0
  9 10  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 10 11  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
  1 20  1  0
 10 12  1  0
  8 26  1  0
M  END

Associated Targets(Human)

EPHB3 Tchem Ephrin type-B receptor 3 (1881 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.83Molecular Weight (Monoisotopic): 361.0982AlogP: 5.22#Rotatable Bonds: 3
Polar Surface Area: 46.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.26CX LogP: 4.15CX LogD: 4.15
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -1.86

References

1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD..  (2009)  Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors.,  19  (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010]

Source